NCT04601428View on ClinicalTrials.gov

Hepatic IA Therapy in Stage B or Limited Stage C Hepatoma (HCC)

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

January 26, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Hepatocellular Carcinoma (HCC)
Interventions
BIOLOGICAL

IA therapy of HCC with CSR02-Fab-TF

Intra-Arterial Infusion of CSR02-Fab-TF

Trial Locations (4)

112

RECRUITING

KFSYSCC, Taipei

11259

RECRUITING

Koo Foundation Sun Yat-Sen Cancer Center (KFSYSCC), Taipei

70403

RECRUITING

National Cheng Kung University Hospital (NCKUH), Tainan City

100225

RECRUITING

National Taiwan University Hospital (NTUH), Taipei

All Listed Sponsors
lead

Koo Foundation Sun Yat-Sen Cancer Center

OTHER